Literature DB >> 10340745

Proximal promoter of the rat brain creatine kinase gene lacks a consensus CRE element but is essential for the cAMP-mediated increased transcription in glioblastoma cells.

E V Kuzhikandathil1, G R Molloy.   

Abstract

Our previous studies have shown that transcription of brain creatine kinase (CKB) mRNA in U87-MG glioblastoma cells is stimulated by a forskolin-mediated increase in cyclic AMP (cAMP) via a pathway involving protein kinase A (PKA) and the activation of Galphas proteins. In this report, we have employed transient transfection to investigate the rat CKB gene elements essential for the cAMP-mediated induction of rat CKB transcription in human U87 cells and have mapped the transcription start site of the induced CKB transcripts. We found that the level of induced transcription from the transfected genomic rat CKB gene was the same whether transcription was driven by 2.9 kb of CKB promoter plus 5' flanking sequence or the 0.2 kb CKB promoter, suggesting that the proximal CKB promoter was essential. Also, the level of induced transcription of the chloramphenicol acetyl transferase (CAT) reporter gene driven by the 2.9 kb CKB promoter was the same as with the 0.2 kb CKB promoter. Analyses of a series of 5' deletions of the 0.2 kb proximal CKB promoter showed that the sequences between -80 bp and +1 bp were essential for the cAMP-mediated induction of CKB transcription, despite the absence of a consensus cAMP response element (CRE) sequence in that region. In agreement, gel mobility shift assays showed that nuclear extracts from U87 cells contained a protein(s) which bound specifically to a [32P]CKB DNA probe containing the -60 bp to +1 bp sequence. Mapping the 5' end of the CKB transcripts showed that the initiation of the cAMP-induced transcription occurred almost exclusively from the downstream transcription start site, apparently under the initiation direction of the nonconsensus (-28) TTAA element and not the consensus (-60) TATAAATA element. The results are discussed with regard to nuclear protein factors which may be involved, and the possible cAMP-mediated increase in CKB transcription during myelinogenesis, since the differentiation of oligodendrocytes has previously been shown to be accelerated by increased intracellular cAMP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340745     DOI: 10.1002/(SICI)1097-4547(19990515)56:4<371::AID-JNR5>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Regulation of the juvenile hormone esterase gene by a composite core promoter.

Authors:  G Jones; Y X Chu; D Schelling; D Jones
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

Review 2.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

3.  Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.

Authors:  Christel Steen; Nadine Wilczak; Johannes M Hoogduin; Marcus Koch; Jacques De Keyser
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

4.  Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, 1H and 31P MRS, and clinical and cognitive testing.

Authors:  Melissa Cambron; Tatjana Reynders; Jan Debruyne; Harmen Reyngoudt; Annemie Ribbens; Erik Achten; Guy Laureys
Journal:  J Neurol       Date:  2018-09-05       Impact factor: 4.849

5.  Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue.

Authors:  Carla Mucignat-Caretta; Luca Denaro; Domenico D'Avella; Antonio Caretta
Journal:  Cancers (Basel)       Date:  2017-12-21       Impact factor: 6.639

6.  Effect of Naringenin on metabolic markers, lipid profile and expression of GFAP in C6 glioma cells implanted rat's brain.

Authors:  S Devan; V A Janardhanam
Journal:  Ann Neurosci       Date:  2011-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.